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Rocking the Cradle
Phthalate Exposure in NICU Infants
Animal studies have linked di(2-ethylhexyl) phthalate
(DEHP) with reproductive and developmental toxicity,
and have demonstrated an especially pronounced effect
on testicular development when administered postnatal-
ly. Previous research has shown that newborns treated at
neonatal intensive care units (NICUs) may receive doses
of DEHP at 2–3 times the average daily adult exposure,
and that these infants have relatively high urinary levels
of the DEHP metabolite mono(2-ethylhexyl) phthalate
(MEHP). Now researchers, using urinary MEHP as a
biomarker of DEHP exposure, demonstrate for the first
time that the more DEHP-containing devices are used in
treating an infant, the more DEHP makes its way into
the infant’s body [EHP 113:1222–1225]. 
Human DEHP exposure is widespread but generally
much lower than the levels causing harm in animal stud-
ies. However, certain circumstances such as intensive
medical treatment can result in higher-than-average
exposure, which may be a particular risk for newborn
males. DEHP is added to polyvinyl chloride (PVC) plas-
tics for use in medical equipment including IV bags, blood bags, and
various types of tubing, as well as many industrial and consumer PVC
products. DEHP does not chemically link to PVC and leaches into
fluids (such as blood and saline solution) that contact the plastic. The
amount of leaching depends upon factors such as type of fluid, length
of storage, and temperature.
The study involved 54 newborn girls and boys receiving treatment
at two Boston-area NICUs between 1 March and 30 April 2003. The
infants had been admitted for various reasons, and treatment included
procedures such as mechanical ventilation, enteral feedings, and car-
diac catheterization. 
Prior to visiting the NICUs, the researchers defined low, medium,
and high DEHP exposure categories based upon typical NICU proce-
dures and equipment. Infants whose treatment consisted primarily of
bottle and/or gavage feedings composed the low-exposure group.
Infants in the medium-exposure group received more invasive thera-
pies involving equipment such as an indwelling gavage tube or umbil-
ical vein catheter. High-exposure infants experienced multiple and
simultaneous invasive treatments, including endotracheal intubation
and continuous umbilical vein catheterization.
One researcher visited the NICUs and observed each infant for
3–12 hours over the course of 1–3 days (more than one infant was
observed at a time). During the observational visits, the researcher
noted the equipment being used for each infant, then assigned the
infant to an exposure group accordingly. At the end of each visit,
urine samples were collected for MEHP measurement. 
The researchers detected 10 phthalate metabolites in the samples,
including 3 associated with DEHP, but focused on MEHP for data
analysis since this metabolite is well studied and a proven biomarker
of DEHP exposure. MEHP levels ranged from less than the level of
detection to 758 nanograms per milliliter and did not vary substan-
tially between multiple individual samples. 
Between the two NICUs there were 13, 24, and 17 infants in the
low-, medium-, and high-exposure groups, respectively. The
researchers found that infants in the high-exposure group had MEHP
levels five times higher than those in the low-exposure group. MEHP
levels for medium-exposure infants were twice those of the low-
exposure group.
The researchers indicate that the MEHP levels seen in this study
are similar to those previously reported for NICU infants and higher
than those reported for older children; no data are available for infants
who did not need NICU care. The relevance of these exposures to
health effects is unknown, and the researchers urge larger, more com-
prehensive studies with follow-up to determine consequences of
DEHP exposure related to NICU treatment. –Julia R. Barrett
Arsenic and Prostate Cancer
Acquiring Androgen Independence
Scientists already suspect that prostate cancer, the second-leading
cause of cancer death in U.S. men, is linked with chronic arsenic
exposure. Now a team of researchers reports that human prostate
cells that underwent chronic, low-level arsenic exposure not only
exhibited aggressive carcinoma-like growth, but also showed an
increased incidence of androgen independence, a state often linked
to advanced or fatal prostate cancers, and one that makes these
cancers more difficult to treat [EHP 113:1134–1139].
Androgen, a sex hormone that stimulates and maintains mas-
culine characteristics, is a necessary component in normal prostate
function that can also encourage the survival and growth of
prostate cancer. That is why some current treatments, such as
pharmaceutical androgen blockers or removal of the testes, focus
on making androgen less available to prostate cancer cells.
However, some patients experience androgen independence, in
which prostate cancer cells no longer need the male hormone to
differentiate and grow out of control. 
The mechanisms behind androgen independence are not com-
pletely understood, but scientists do know that this phenomenon
sometimes occurs when androgen receptors go functionally awry.
In some cases, the androgen receptors are “overexpressed,” greatly
increasing in number. In other cases, the receptors mutate, which
can result in hyperresponsiveness to androgens. Still other receptor
mutations allow nonandrogens (such as the estrogens) and even
androgen inhibitors to stimulate cancer growth. Sometimes andro-
gen receptors are bypassed completely, and cell growth is activated
by other naturally occurring compounds including insulin-like
growth factor-1, epidermal growth factor, and others.
In the current study, researchers examined the growth of nor-
mal and arsenic-transformed human prostate epithelial cells. The
Double jeopardy? Babies in neonatal intensive care units, already a high-risk group, are
likely to have greater exposure to potentially harmful phthalates than other children.Science Selections
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arsenic-transformed cells had been exposed continuously to sodium
arsenite and, after 29 weeks of exposure, produced malignant
tumors when inoculated into nude mice. Both cell lines were
observed in two different media. One medium included the com-
plete range of steroids, including ample amounts of androgen and
growth factors. The other lacked normal amounts of sex hormones
and growth factors. 
The experiment showed that, consistent with malignant cell
growth, prostate cells chronically exposed to arsenic grew more
rapidly than control cells in both media. In the steroid-rich medi-
um, the arsenic-transformed cells proliferated approximately twice
as fast as the unexposed control cells. In the steroid-depleted medi-
um, the arsenic-transformed cells proliferated about 2.5 times
faster than control cells. 
Arsenic exposure therefore appeared to be associated with the
acquisition of androgen independence in prostate cells. However,
the observed arsenic-induced androgen independence did not
occur by any previously studied mechanism; it was not linked to
overexpression of androgen receptors or receptor mutations that
facilitate cell growth via nonandrogens. 
A clue may lie in earlier experiments, in which the same
researchers observed a marked increase in production of K-ras (an
oncogene associated with prostate cancers) in arsenic-transformed
cells. K-ras is a key part of a growth-stimulating pathway in the
prostate that is stimulated by androgens. K-ras was clearly corre-
lated with arsenic-induced carcinoma-like growth and androgen
independence. The authors speculate here that arsenic may by-
pass the androgen receptor and direct-
ly cause aberrant K-ras activation.
–John Tibbetts
Air Pollution in
Space and Time
Birth Outcomes Are
Complicated by Exposure
Variations
The association between air pollution
and adverse effects on human birth
outcomes is drawing increasing atten-
tion worldwide. In one of the latest
developments, two epidemiologists at
the University of California, Los
Angeles, have found that the typical
use of air pollution data from fixed
monitoring stations may be inadequate
for accurately pinpointing the links
between air pollution and birth out-
comes [EHP 113:1212–1221]. They
also corroborate earlier findings that
timing of pollution exposures is signif-
icant and that studying different pol-
lutant combinations substantially
complicates analysis.
Using new data in a follow-up on
previous work, the researchers discov-
ered that carbon monoxide (CO) and
particulate matter (PM10) had signifi-
cant adverse effects—and at concentra-
tions well below U.S. federal standards—
on preterm and low-birth-weight
(LBW) births for women living within one mile of an air pollution
monitoring station. However, they measured substantially less or
no effect for women living just two to four miles away. They also
found the effects were most pronounced in association with expo-
sure during early and late gestation, but less apparent for the full
pregnancy.
The researchers used state and county databases documenting
births to mothers living in the Los Angeles area from 1994 to
2000. To analyze LBW at full term, they studied a zip code cohort
of 136,134 births, of which 2,778 were LBW. To analyze preterm
births, they used 106,483 of the same births (minus births by
cesarean section), of which 9,268 were preterm. Data from 18 gov-
ernment air pollution monitors documented CO, PM10, nitrogen
dioxide, and ozone levels. There were two years of data for fine
particulate matter (PM2.5), but the researchers found that wasn’t a
long enough period to provide significant findings (although many
other studies have found that PM2.5 is more of a health concern
than PM10).
The researchers discovered that for the first trimester, the high-
est quartile of CO concentrations observed—never more than two-
thirds of the U.S. Environmental Protection Agency (EPA) 8-hour
standard—was associated with a 27% increase in risk of preterm
birth for women living within one mile of a pollution monitoring
station. Similar CO exposures and distances during the third
trimester were associated with a 36% increase in LBW following a
full-term pregnancy. Parallel effects were seen for PM10—which
never exceeded two-thirds of the EPA 24-hour standard—early
Born of necessity. A study of Los Angeles mothers shows that more detailed exposure information is criti-
cal for accurately drawing links between air pollution and adverse birth outcomes.and late in pregnancy. This generally confirmed findings from an
earlier study using data from 1989 to 1993. No significant relation-
ships were seen for nitrogen dioxide or ozone.
The researchers were able to account for many potentially
confounding factors, including maternal age, level of prenatal
care, and infant’s sex. However, they had no data for other factors
known to influence birth outcomes, such as maternal occupation,
height, weight, weight gain during pregnancy, and smoking sta-
tus. Folding in such data could affect the outcome of this study,
the team acknowledges. The team’s finding that effect estimates
diminished for women living farther than one mile from a station
suggests that the air monitoring stations may not provide accurate
measures of exposure for these women; development of ways to
better capture spatial variability in pollutant concentrations is
therefore an important goal.
The researchers concluded that improved air pollutant data
reflecting both geographic variation and the specific substances in
the ambient air mixture will lead to much better understanding of
air pollutants on birth effects. Also important are the use of finer
breakdowns of the pregnancy period and more detailed background
information on the parents and child. –Bob Weinhold
When Lead Goes to 
Your Head
Genotype May Link
Exposure and Meningioma
Scientists know very little about the
causes of most brain tumors. A small
percentage of cases can be explained by
familial syndromes, or by exposure to
ionizing radiation, but the precise roles
of specific genes or other environmental
factors, such as lead, remain largely
unexplored. A research team now
reports an association between a genetic
variant for δ-aminolevulinic acid dehy-
dratase (ALAD)—an enzyme involved
in the synthesis of heme—and an
increased risk of developing menin-
gioma, a tumor that occurs in the mem-
branes covering the brain and the spinal
cord [EHP 113:1209–1211]. 
Some previous studies suggested that
people who carry an ALAD polymor-
phism known as ALAD2 tend to have
higher concentrations of lead in their
blood. Other research has indicated that
occupational exposure to lead may
increase the risk of meningioma. The
findings of the current study suggest a
possible link between these two results.
The team discovered a connection
between ALAD2 and meningioma in a
study of 573 patients with brain tumors
from hospitals in Arizona, Massa-
chusetts, and Pennsylvania. The patients
were compared to 505 control subjects
who were admitted to the same hospitals
for conditions that did not involve
tumors. Of the brain tumor patients,
151 had meningioma, 355 had glioma
(a cancer that grows from glial cells in the brain), and 67 had
acoustic neuroma (a tumor of the auditory nerve). 
The ALAD genotype—based on the ALAD1 and ALAD2 alleles—
was determined for each patient and each control subject. Possible
links between the ALAD2 allele and the brain tumors were investi-
gated using unconditional logistic regression. 
The statistical analyses revealed that people who carried the
ALAD2 allele (heterozygotes and homozygotes) were 1.6 times
more likely than the ALAD1 homozygotes to develop meningioma.
This modest but significant association was stronger in males, who
were 3.5 times more likely to develop meningioma if they had the
variant allele. However, the authors caution that their sample size
may be too small to draw conclusions about gender-related effects.
They saw no increased risk linked with the ALAD2 allele for glioma
or acoustic neuroma.
These results raise the question of how the ALAD2 allele might
increase the risk of meningioma. Previous work by the same team,
based on the same study subjects, found an elevated risk of menin-
gioma for occupational groups that may be exposed to lead, including
auto body painters and industrial production supervisors. Certain
other studies have shown that individuals who carry the ALAD2 allele
have higher levels of lead in their blood. Together, these results sug-
gest that lead may play a role in the link between the ALAD2 allele
and meningioma. The researchers recommend that future investiga-
tions should consider the combined effects of exposure to lead and
the ALAD2 allele on the incidence of this cancer. –Michael Szpir
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Chasing leads on brain tumors. Information on what causes brain tumors is fragmented; however, new
data may tie together clues about lead exposure and a predisposition to develop meningioma.